Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-03

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Eywa Pharma Inc)

View source ↗

Summary

FDA approved Eywa Pharma Inc's methylphenidate hydrochloride under an original ANDA, adding a generic option for ADHD treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate hydrochloride (generic) (Methylphenidate hydrochloride)

Snippet

ORIG AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)